VAERS reports by lot

GSK Hepatitis A lot 333M4: VAERS reports

31 VAERS reports list lot 333M4 as a GSK Hepatitis A vaccine, received between 2022-06-04 and 2024-08-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological250%
Cardiac / Cardiovascular125%
Injection-site / Local reaction125%

Where reports came from

U.S. state of the reporter, where given (top 12).

Colorado5
Michigan4
Pennsylvania3
New Jersey2
Wisconsin2
West Virginia2
Kentucky2
Utah1
Puerto Rico1
Virginia1
California1
Idaho1

Reports by month received

2022-061
2022-072
2022-082
2022-091
2022-103
2022-123
2023-011
2023-022
2023-031
2023-054
2023-061
2023-072
2023-081
2023-091
2023-112
2024-011
2024-041
2024-051
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.